Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 1, 2025
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
GlobeNewswire
·
April 1, 2025
Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the role of the test in prompting use of …
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
GlobeNewswire
·
April 1, 2025
VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement
GlobeNewswire
·
April 1, 2025
RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement of approximately …
Stryker completes sale of U.S. spinal implants business
GlobeNewswire
·
April 1, 2025
Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly …
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that company management will …
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster …
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
GlobeNewswire
·
April 1, 2025
SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug …
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, the compensation committee of Biomea’s …
Conavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive Plan
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide …
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
GlobeNewswire
·
April 1, 2025
MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR1 trial of TLX300-CDx (89Zr-olaratumab) in patients …
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT. About LeMaitre …
ProDentim Reviews (DOCTOR WARNING): Dentists & Buyers Reveal the Truth Behind This “Natural Smile Fix” Supplement
GlobeNewswire
·
April 1, 2025
Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of oral health solutions, ProDentim has rapidly become one of the most talked-about probiotic supplements. With claims of revolutionary results flooding the market, it's …
Nagano Tonic Reviews (2025 WARNING): What Buyers Discovered About This Ancient Fat Burner From Japan
GlobeNewswire
·
April 1, 2025
ORLANDO, April 01, 2025 (GLOBE NEWSWIRE) -- NAGANO TONIC The search for a reliable, natural weight loss solution is an endless battle for many. With countless supplements flooding the market—each promising rapid fat loss—it's no surprise that consumers …
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
GlobeNewswire
·
April 1, 2025
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France), April 1, 2025 – Valneva SE (Nasdaq: …
Valneva : le vaccin contre le chikungunya, IXCHIQ®, désormais autorisé chez les adolescents dans l'UE
GlobeNewswire
·
April 1, 2025
Avec cet élargissement d’indication, IXCHIQ®, le premier vaccin autorisé au monde contre le virus du chikungunya (CHIKV), est désormais disponible pour une administration dans l'Union Européenne (UE) chez les personnes âgées de 12 ans et plus. Saint …
ProDentim Reviews (DOCTOR INVESTIGATES): The Probiotic Dental Hack Dentists Can’t Ignore in 2025
GlobeNewswire
·
April 1, 2025
ORLANDO, FL, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of oral health solutions, ProDentim has rapidly become one of the most talked-about probiotic supplements. With claims of revolutionary results flooding the market, it's …
Prime Biome (INVESTIGATIVE REPORT): Does This Trending Gut Reset Supplement Actually Deliver Real Results?
GlobeNewswire
·
April 1, 2025
DENVER, April 01, 2025 (GLOBE NEWSWIRE) -- At a time when nearly every health product claims to support digestion, reduce inflammation, or rewind the clock on aging, one name is rising through the noise: Prime Biome. Promoted as a next-generation probiotic …
Mitolyn Reviews: DON’T SKIP UNTIL YOU READ THIS MEDICAL BREAKDOWN – Legit or Empty Promises?
GlobeNewswire
·
April 1, 2025
Orlando, FL, April 01, 2025 (GLOBE NEWSWIRE) -- MITOLYN OFFICIAL With the massive flood of weight loss and energy-boosting supplements on the market, it’s easy to be skeptical of Mitolyn. Is it truly a science-backed solution for metabolism and fat loss, …
GRI Bio Announces Pricing of $5.0 Million Public Offering
GlobeNewswire
·
April 1, 2025
LA JOLLA, CA, April 01, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …